KRINGLE PHARMA, INC.

Press Releases Kringle Pharma, Inc.

Equities

4884

JP3270790003

Market Closed - Japan Exchange Other stock markets 11:30:00 24/05/2024 am IST			5-day change	1st Jan Change
595 ^JPY	-2.62%		-8.46%	-20.88%

09/02	Kringle Pharma, Inc. Provides Earnings Guidance for the Fiscal Year Ending September 30, 2024	CI
2023	Kringle Pharma, Inc. Provides Earnings Guidance for the Fiscal Year Ending September 30, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kringle Pharma : Update on the Investigator-initiated Phase 2 Study in Patients with ALS	12/22/12	PU
Kringle Pharma : Research Collaboration with Kyoto University in Biomaterial-assisted Regenerative Medicine using HGF	01/22/01	PU
Kringle Pharma : Files Patent Application for Treatment of Chronic Spinal Cord Injury	11/22/11	PU
Kringle Pharma : Erratum to the Press Release “Kringle Pharma Appoints Hideyuki Okano, M.D., Ph.D. as Scientific Advisor” dated March 1, 2022	03/22/03	PU
Kringle Pharma : Appoints Hideyuki Okano, M.D., Ph.D. as Scientific Advisor	01/22/01	PU
Kringle Pharma : Financial Results for the Three Months Ended December 31, 2021(Non-consolidated)	28/22/28	PU
Kringle Pharma : Strengthens IP Portfolio with the Formulation Patent in Europe.	29/21/29	PU
Kringle Pharma : ［Delayed］Financial Results for the Fiscal Year Ended September 30, 2021 (Non-consolidated)	17/21/17	PU
Kringle Pharma : Last Patient Out in Phase 2 Study of KP-100IT for the Treatment of ALS	09/21/09	PU
Kringle Pharma : Financial Results for the Nine Months Ended June 30, 2021(Non-consolidated)	20/21/20	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer